Company Name: Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in the development of therapies for orphan and rare diseases with a focus on lysosomal storage disorders. The company’s pipeline includes product candidates designed to treat Fabry disease, Epidermolysis Bullosa and Pompe disease.
Ticker Symbol: FOLD (NASDAQ)
Company Website: www.amicusrx.com
Headquarters: Cranbury, NJ